Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
piperacillintazobactam (10) 10
index medicus (7) 7
humans (6) 6
piperacillin-tazobactam (6) 6
internal medicine (5) 5
dosage and administration (4) 4
medicine & public health (4) 4
pharmacology & pharmacy (4) 4
pharmacology/toxicology (4) 4
pharmacotherapy (4) 4
risk factors (4) 4
amoxicillinclavulanic-acid (3) 3
gentamicin (3) 3
linezolid (3) 3
meropenem (3) 3
toxicology (3) 3
vancomycin (3) 3
animals (2) 2
anti-bacterial agents - administration & dosage (2) 2
anti-infective agents (2) 2
anti-infective agents - therapeutic use (2) 2
antibiotic-therapy (2) 2
antibiotics (2) 2
cefepime (2) 2
ceftazidime (2) 2
ciprofloxacin (2) 2
community-acquired pneumonia (2) 2
complications and side effects (2) 2
drug therapy (2) 2
ertapenem (2) 2
female (2) 2
imipenemcilastatin (2) 2
in-vitro activity (2) 2
intensive-care-unit (2) 2
levofloxacin (2) 2
male (2) 2
moxifloxacin (2) 2
neutropenia (2) 2
penicillanic acid - analogs & derivatives (2) 2
practice guidelines (2) 2
prevention (2) 2
tazobactam (2) 2
tigecycline (2) 2
abdomen (1) 1
abscess (1) 1
acrylic resins - chemistry (1) 1
acrylic-acid (1) 1
adult icu patients (1) 1
adverse effects (1) 1
alkaline phosphatase - blood (1) 1
amikacin (1) 1
aminoglycosides (1) 1
ampicillin (1) 1
ampicillin - administration & dosage (1) 1
anaerobic infections (1) 1
anaerobic-infections, treatment (1) 1
anemia (1) 1
anti-bacterial agents (1) 1
anti-bacterial agents - adverse effects (1) 1
anti-bacterial agents - chemistry (1) 1
anti-bacterial agents - pharmacokinetics (1) 1
anti-bacterial agents - pharmacology (1) 1
anti-bacterial agents - therapeutic use (1) 1
antibacterial agents (1) 1
antibacterials (1) 1
antibiotic exposure (1) 1
antibiotic-resistance (1) 1
antimicrobial susceptibility (1) 1
apgar score (1) 1
artificial respiration (1) 1
azithromycin (1) 1
bacteria, anaerobic - drug effects (1) 1
bacteria, anaerobic - isolation & purification (1) 1
bacterial pneumonia (1) 1
bacteroides-fragilis group (1) 1
bandages (1) 1
biapenem (1) 1
biochemical phenomena, metabolism, and nutrition (1) 1
biocompatible materials - chemistry (1) 1
biocompatible materials - pharmacology (1) 1
biomarkers - analysis (1) 1
body fluid compartments - metabolism (1) 1
bone marrow (1) 1
brief report (1) 1
bronchoalveolar lavage fluid - chemistry (1) 1
bronchoalveolar lavage fluid - microbiology (1) 1
c-reactive protein (1) 1
cancer-chemotherapy (1) 1
carbapenemase gene cfia (1) 1
carbapenems (1) 1
carbapenems, therapeutic use (1) 1
care and treatment (1) 1
cefaclor (1) 1
cefdinir (1) 1
cefditoren (1) 1
cefotaxime (1) 1
cefpirome (1) 1
cefpodoxime-proxetil (1) 1
ceftazidime plus amikacin (1) 1
ceftazidime-avibactam (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Repeated piperacillin-Tazobactam plasma concentration measurements in severely obese versus nonobese critically III Septic patients and the risk of under-And overdosing
by Jung, Boris and Mahul, Martin and Breilh, Dominique and Legeron, Rachel and Signe, Jeremy and Jean-Pierre, Helene and Uhlemann, Anne-Catrin and Molinari, Nicolas and Jaber, Samir
Critical Care Medicine, ISSN 0090-3493, 05/2017, Volume 45, Issue 5, pp. e470 - e478
Obesity | Septic shock | Monte carlo simulation | Piperacillintazobactam | Population pharmacokinetic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prolonged Infusions: The Significance of How
by Colton, Benjamin
Critical Care Medicine, ISSN 0090-3493, 02/2018, Volume 46, Issue 2, pp. 333 - 335
Prolonged infusion | Continuous infusion | Piperacillintazobactam | Extended infusion | MORTALITY | extended infusion | piperacillin-tazobactam | continuous infusion | prolonged infusion | CRITICAL CARE MEDICINE | Piperacillin, Tazobactam Drug Combination | Tazobactam | Anti-Bacterial Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
: Focus on Antibacterial Agents
by Rodvold, Keith A and George, Jomy M and Yoo, Liz
Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 637 - 664
The exposure-response relationship of anti-infective agents at the site of infection is currently being re-examined. Epithelial lining fluid (ELF) has been... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Iclaprim | Linezolid | Levofloxacin | Clarithromycin | Cefepime | Gentamicin | Azithromycin | Roxithromycin | Cefdinir | Moxifloxacin | Vancomycin | Teicoplanin | Ceftobiprole | Antibacterials | Amoxicillinclavulanic-acid | Cefditoren | Cefpodoxime-proxetil | Pulmonary-lavage | Meropenem | Interstitial-fluid | Piperacillintazobactam | Cefaclor | Ceftazidime | Netilmicin | Cefpirome | Dirithromycin | Telithromycin | Pharmacology | Erythromycin | Ertapenem | Modithromycin | Cethromycin | Telavancin | Ceftibuten | Tobramycin | Biapenem | Ciprofloxacin | Oritavancin | Pharmacokinetics | Tigecycline | Cefuroxime-axetil | COMMUNITY-ACQUIRED PNEUMONIA | VENTILATOR-ASSOCIATED PNEUMONIA | SEVERE NOSOCOMIAL PNEUMONIA | KETOLIDE ANTIMICROBIAL AGENT | HEALTHY ADULT SUBJECTS | PHARMACOLOGY & PHARMACY | MONTE-CARLO-SIMULATION | RESISTANT STREPTOCOCCUS-PNEUMONIAE | STEADY-STATE PLASMA | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | Epithelium - metabolism | Humans | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Tissue Distribution | Models, Biological | Body Fluid Compartments - metabolism | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Lung - metabolism | Bronchoalveolar Lavage Fluid - chemistry | Macrophages, Alveolar - metabolism | Anti-Bacterial Agents - administration & dosage | Monte Carlo Method
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Essentials for Selecting Antimicrobial Therapy for Intra-Abdominal Infections
by Blot, Stijn and De Waele, Jan J and Vogelaers, Dirk
Drugs, ISSN 0012-6667, 4/2012, Volume 72, Issue 6, pp. e17 - e32
Intra-abdominal infection (IAI) is a complex disease entity in which different aspects must be balanced in order to select the proper antimicrobial regimen and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Fluoroquinolones | Linezolid | Doripenem | Daptomycin | Intra-abdominal-infections | Aminoglycosides | Moxifloxacin | Quinupristindalfopristin | Amoxicillinclavulanic-acid | Imidazoles | Cephalosporins | Imipenemcilastatin | Meropenem | Carbapenems | Piperacillintazobactam | Tigecycline | Glycopeptides | SECONDARY PERITONITIS | RISK-FACTORS | INTENSIVE-CARE-UNIT | MULTIDRUG-RESISTANT BACTERIA | ESCHERICHIA-COLI | PHARMACOLOGY & PHARMACY | POSTOPERATIVE PERITONITIS | TOXICOLOGY | DISEASES SOCIETY | INVASIVE CANDIDIASIS | ANTIBIOTIC-THERAPY | SEVERE SEPSIS | Severity of Illness Index | Anti-Infective Agents - therapeutic use | Intraabdominal Infections - drug therapy | Humans | Risk Factors | Prevention | Usage | Abscess | Anti-infective agents | Dosage and administration | Health aspects | Abdomen | Therapy In Practice
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water
by Meyer, Kevin and Santarossa, Maressa and Danziger, Larry H and Wenzler, Eric
Hospital Pharmacy, ISSN 0018-5787, 3/2017, Volume 52, Issue 3, pp. 221 - 228
Objectives The compatibility of vancomycin with existing and novel β-lactam/β-lactamase inhibitors at clinically relevant concentrations in 5% dextrose in... 
Ceftolozane-tazobactam | Vancomycin | Compatibility | Piperacillintazobactam | Ceftazidime-avibactam | Dextrose | dextrose | ceftolozane-tazobactam | vancomycin | ceftazidime-avibactam | Original | compatibility | piperacillin-tazobactam
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Sequential antibiotic and growth factor releasing chitosan-PAAm semi-IPN hydrogel as a novel wound dressing
by Pulat, Mehlika and Kahraman, Anıl Sera and Tan, Nur and Gümüşderelioğlu, Menemşe
Journal of Biomaterials Science, Polymer Edition, ISSN 0920-5063, 05/2013, Volume 24, Issue 7, pp. 807 - 819
The aim of this study is to prepare a novel wound dressing material which provides burst release of an antibiotic in combination with sustained release of... 
chitosan | sequential release | EGF | cell culture | semi-IPN hydrogels | piperacillin-tazobactam | MATERIALS SCIENCE, BIOMATERIALS | POLYMER SCIENCE | PIPERACILLIN-TAZOBACTAM | ENGINEERING, BIOMEDICAL | SWELLING BEHAVIOR | DELIVERY | piperacillintazobactam | CHITIN | ACRYLIC-ACID | Cell Line | Wounds and Injuries - surgery | Bandages | Biocompatible Materials - chemistry | Piperacillin - chemistry | Biocompatible Materials - pharmacology | Acrylic Resins - chemistry | Penicillanic Acid - chemistry | Animals | Chitosan - chemistry | Anti-Bacterial Agents - chemistry | Epidermal Growth Factor - chemistry | Water - chemistry | Mice | Kinetics | Hydrogels - chemistry | Penicillanic Acid - analogs & derivatives
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Hematologic Adverse Effects of Prolonged Piperacillin-Tazobactam Use in Adults
by Benli, A and Simsek-Yavuz, S and Basaran, S and Cagatay, A and Ozsut, H and Eraksoy, H
TURKISH JOURNAL OF HEMATOLOGY, ISSN 1300-7777, 12/2018, Volume 35, Issue 4, pp. 290 - 295
Objective: We aimed to find the incidence and risk factors of hematologic adverse effects of piperacillin-tazobactam (TZP). Materials and Methods: Adult... 
INFECTIONS | Leukopenia | Piperacillin-tazobactam | Adverse effects | HEMATOLOGY | Eosinophilia | Neutropenia | Humans | Middle Aged | Risk Factors | Female | Leukopenia - drug therapy | Male | Eosinophilia - drug therapy | Piperacillin, Tazobactam Drug Combination - adverse effects | Neutropenia - drug therapy | Statistical analysis | Comorbidity | Anemia | Systematic review | Multivariate analysis | Patients | Risk factors | Fever | Antibiotics | Hemoglobin | Data collection | Bone marrow | Nosocomial infections | Drug dosages | Brief Report | Piperacillintazobactam
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Diagnosis, management and prevention of ventilator-associated pneumonia: An update
by Vincent, Jean-Louis and De Souza Barros, Dalton and Cianferoni, Silvia
Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 15, pp. 1927 - 1944
Ventilator-associated pneumonia (YAP) affects 10-20% of mechanically ventilated patients and is associated with increased morbidity and mortality and high... 
Linezolid | Levofloxacin | Selective-gastrointestinal-decontamination | Amikacin | Cefepime | Cefotaxime | Gentamicin | Vancomycin | Ertapenem | Cefuroxime | Amoxicillinclavulanic-acid | Imipenemcilastatin | Nosocomial-pneumonia | Meropenem | Ciprofloxacin | Piperacillintazobactam | Ceftazidime | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | COMMUNITY-ACQUIRED PNEUMONIA | GRAM-NEGATIVE BACTERIA | INTENSIVE-CARE-UNIT | COATED ENDOTRACHEAL-TUBES | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ADULT ICU PATIENTS | SUBGLOTTIC SECRETION DRAINAGE | REQUIRING MECHANICAL VENTILATION | ANTIBIOTIC-THERAPY | Humans | Biomarkers - analysis | Clinical Protocols | Pneumonia, Ventilator-Associated - prevention & control | Anti-Infective Agents - therapeutic use | Pneumonia, Ventilator-Associated - etiology | Early Diagnosis | Cross Infection - drug therapy | Pneumonia, Ventilator-Associated - diagnosis | Pneumonia, Ventilator-Associated - drug therapy
Journal Article
Details down arrow
9. Anaerobic infections: Update on treatment considerations
by Nagy, Elisabeth
Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 7, pp. 841 - 858
Anaerobic bacteria are the predominant indigenous flora of humans and, as a result, play an important role in infections, some of which are serious with a high... 
Carbapenems, therapeutic use | Piperacillintazobactam, therapeutic use | Tigecycline, therapeutic use | Metronidazole, therapeutic use | Clindamycin, therapeutic use | Anaerobic-infections, treatment | Cephamycins, therapeutic use | Moxifloxacin, therapeutic use | ANTIMICROBIAL SUSCEPTIBILITY | PENICILLIN-BINDING PROTEINS | ANTIBIOTIC-RESISTANCE | FLUOROQUINOLONE RESISTANCE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | NITROIMIDAZOLE RESISTANCE | METRONIDAZOLE RESISTANCE | BACTEROIDES-FRAGILIS GROUP | CARBAPENEMASE GENE CFIA | IN-VITRO ACTIVITY | CLOSTRIDIUM-DIFFICILE | Gram-Negative Anaerobic Bacteria - isolation & purification | Humans | Gram-Negative Bacterial Infections - drug therapy | Gram-Positive Bacterial Infections - epidemiology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Bacteria, Anaerobic - isolation & purification | Animals | Gram-Positive Bacterial Infections - microbiology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - adverse effects | Bacteria, Anaerobic - drug effects | Gram-Negative Anaerobic Bacteria - drug effects | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Drug Resistance, Multiple, Bacterial - drug effects
Journal Article
Details down arrow
10. Full Text Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤1500 g
by Chong, E and Reynolds, J and Shaw, J and Forur, L and Delmore, P and Uner, H and Bloom, B.T and Gordon, P
Journal of Perinatology, ISSN 0743-8346, 07/2013, Volume 33, Issue 7, pp. 529 - 532
OBJECTIVE: We changed from ampicillin and gentamicin (AG) to piperacillin-tazobactam (PT) for routine treatment of suspected early-onset sepsis. The rationale... 
gentamicin | necrotizing enterocolitis | ampicillin | piperacillintazobactam | diaper rash | IN-VITRO | EARLY-ONSET SEPSIS | ANTIBIOTIC EXPOSURE | RISK | PEDIATRICS | piperacillin-tazobactam | OBSTETRICS & GYNECOLOGY | Infant, Very Low Birth Weight | Humans | Male | Treatment Outcome | Ampicillin - administration & dosage | Gentamicins - administration & dosage | Infant, Premature, Diseases - drug therapy | Sepsis - drug therapy | Diaper Rash - prevention & control | Apgar Score | Infant, Premature | Penicillanic Acid - therapeutic use | Female | Retrospective Studies | Sepsis - congenital | Alkaline Phosphatase - blood | Infant, Newborn | Penicillanic Acid - analogs & derivatives | Piperacillin - therapeutic use | Sepsis | Dosage and administration | Drug therapy, Combination | Drug therapy | Patient outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text An evidence based review of the available antibiotic treatment options for neutropaenic patients and a recommendation for treatment guidelines
by Glasmacher, Axel and von Lilienfeld-Toal, Marie
International Journal of Infectious Diseases, ISSN 1201-9712, 2006, Volume 10, Issue 2, pp. S9 - S16
Effective empirical antimicrobial therapy has led to a better outcome for febrile neutropenic patients. Guidelines are based mainly on expert opinion, current... 
Febrile | Review | Piperacillintazobactam | Neutropenia | Guidelines | CEFTAZIDIME PLUS AMIKACIN | FEBRILE NEUTROPENIC PATIENTS | INFECTIOUS DISEASES | MONOTHERAPY | METAANALYSIS | PIPERACILLIN-TAZOBACTAM | CANCER-CHEMOTHERAPY | tazobactam | neutropenia | PERSISTENT FEVER | review | DOUBLE-BLIND | guidelines | piperacillin | PLACEBO-CONTROLLED TRIAL | EMPIRIC THERAPY | febrile | Antibiotics | Practice guidelines (Medicine) | Evidence-based medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.